Fetal growth restriction (FGR), defined as a birthweight under the 3rd centile¹, is the major cause of stillbirth as well as infant mortality and morbidity^2-6. FGR is highly associated with dysfunction of placenta during pregnancy. Centaflow A/S has developed a new and groundbreaking technology for identifying abnormal functions of placenta and FGR – the Centaflow biocensor (CB). The technology is developed to be used by midwives in the pregnancy care system to improve identification of FGR. No new technology has been implemented for decades in the Danish pregnancy care system. And it is well known that implementation of new technology in health care and among midwives is often complicated and many implementations fail to succeed^7-11. Implementation of new technology has a high level of complexity due to many stakeholders and a complex setting^12,13. Therefore, it is essential to involve stakeholders in the process of implementation^14,15. Some stakeholders for CB are midwives, pregnant women, and their partners. The overall objective of this industrial PhD project is to contribute with new knowledge that will improve the clinical detection of placentas with dysfunction, FGR and reduce stillbirth, neonatal mortality, and short and long-term morbidity of FGR infants and to filling important knowledge gaps regarding implementation of technologies in health systems in general and how service innovation can be achieved - leading to better and safer care and improved health. Specifically, this study aims to identify drivers and barriers for implementation of new technology in midwifery consultations and explore how implementation activities are adapted and interact with the contextual factors of the different settings. It will address three research questions through three sub-studies: 1) A case study: The implementation process of the Centaflow screening technology and the new paradigm for finding dysfunctional placentas and FGR within different pregnancy care settings using the “nonadoption, abandonment, scale-up, spread and sustainability” (NASSS) framework developed to improve implementation and innovation in the health sector^16-18. 2) Qualitative focus group interviews: Midwives’ attitudes towards and experiences of the Centaflow screening technology and the change in paradigm. 3) Qualitative interviews: Pregnant women’s assessment of the Centaflow screening technology and how it affects their experience of and attitudes towards the midwifery consult as well as sense of security throughout pregnancy. The PhD project will develop scientific, evidence-based strategies for implementation of the new approach to screening for FGR in Denmark with a high level of stakeholder involvement.